Literature DB >> 21172291

Infliximab therapy for HIV positive Crohn's disease: A case report.

Syed F Habib1, Muhammad Z Hasan, I Salam.   

Abstract

Anti-TNF-alpha is now established as a major player in the treatment of Crohn's disease, however the use of anti-TNF-alpha therapy in patients concomitantly having HIV infection and Crohn's disease is a relatively unexplored subject. There is generally some apprehension and anxiety to use infliximab in patients with HIV. One case has been reported in literature of usage of anti-TNF-alpha in HIV positive patient with Crohn's disease who was on anti-retroviral therapy. We report for the first time the successful usage of infliximab in treating Crohn's disease in an HIV positive patient who is not on any anti-retroviral treatment.

Entities:  

Year:  2009        PMID: 21172291     DOI: 10.1016/j.crohns.2009.06.002

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  5 in total

1.  Successful treatment of severe perianal Crohn's disease with infliximab in an HIV-positive patient.

Authors:  Maria Ana Rafael; Luís Carvalho Lourenço; Ana Maria Oliveira; Teresa Branco; Carla Carneiro; Ana Costa; Jorge Reis
Journal:  Clin J Gastroenterol       Date:  2019-05-20

Review 2.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

3.  Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.

Authors:  Andrea Lisco; Chun-Shu Wong; Silvia Lucena Lage; Itzchak Levy; Jason Brophy; Jeffrey Lennox; Maura Manion; Megan V Anderson; Yolanda Mejia; Christopher Grivas; Harry Mystakelis; Peter D Burbelo; Ainhoa Perez-Diez; Adam Rupert; Craig A Martens; Sarah L Anzick; Caryn Morse; Shanna Chan; Claire Deleage; Irini Sereti
Journal:  JCI Insight       Date:  2019-04-18

4.  Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.

Authors:  Marc Beyer; Zeinab Abdullah; Jens M Chemnitz; Daniela Maisel; Jil Sander; Clara Lehmann; Yasser Thabet; Prashant V Shinde; Lisa Schmidleithner; Maren Köhne; Jonel Trebicka; Robert Schierwagen; Andrea Hofmann; Alexey Popov; Karl S Lang; Annette Oxenius; Thorsten Buch; Christian Kurts; Mathias Heikenwalder; Gerd Fätkenheuer; Philipp A Lang; Pia Hartmann; Percy A Knolle; Joachim L Schultze
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

5.  Clinical use of anti-TNF therapy and increased risk of infections.

Authors:  Tauseef Ali; Sindhu Kaitha; Sultan Mahmood; Abdul Ftesi; Jordan Stone; Michael S Bronze
Journal:  Drug Healthc Patient Saf       Date:  2013-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.